Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phage therapy experience at the Eliava Institute.

Literature DB >> 18687542

Phage therapy experience at the Eliava Institute.

Abstract

The rapid spread of multidrug resistant bacterial strains limits the effectiveness of antibiotic treatments and induces intense research for alternatives. Today, the use of phage preparations as alternative approach is gaining attention, particularly for treating a wide variety of diseases which are difficult to control by chemotherapeutic agents. This article relates the phage therapy experience of the Eliava Institute of Bacteriophage, Microbiology and Virology.

Entities: Species

Mesh：

Year: 2008 PMID： 18687542 DOI： 10.1016/j.medmal.2008.06.023

Source DB: PubMed Journal: Med Mal Infect ISSN： 0399-077X Impact factor: 2.152

Keyword Cloud
Cited

67 in total

1. Impact of relative humidity and collection media on mycobacteriophage D29 aerosol.

Authors: Keyang Liu; Zhanbo Wen; Na Li; Wenhui Yang; Jie Wang; Lingfei Hu; Xiaokai Dong; Jianchun Lu; Jinsong Li
Journal: Appl Environ Microbiol Date: 2011-12-22 Impact factor: 4.792

2. Evaluation of the Activity of a Combination of Three Bacteriophages Alone or in Association with Antibiotics on Staphylococcus aureus Embedded in Biofilm or Internalized in Osteoblasts.

Authors: Camille Kolenda; Jérôme Josse; Mathieu Medina; Cindy Fevre; Sébastien Lustig; Tristan Ferry; Frédéric Laurent
Journal: Antimicrob Agents Chemother Date: 2020-02-21 Impact factor: 5.191

3. Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections.

Authors: Sharon S Y Leung; Thaigarajan Parumasivam; Fiona G Gao; Nicholas B Carrigy; Reinhard Vehring; Warren H Finlay; Sandra Morales; Warwick J Britton; Elizabeth Kutter; Hak-Kim Chan
Journal: Pharm Res Date: 2016-02-29 Impact factor: 4.200

4. Storage stability of inhalable phage powders containing lactose at ambient conditions.

Authors: Rachel Yoon Kyung Chang; Martin Wallin; Elizabeth Kutter; Sandra Morales; Warwick Britton; Jian Li; Hak-Kim Chan
Journal: Int J Pharm Date: 2019-01-31 Impact factor: 5.875

5. Applying the ResFinder and VirulenceFinder web-services for easy identification of acquired antibiotic resistance and E. coli virulence genes in bacteriophage and prophage nucleotide sequences.

Authors: Kortine Annina Kleinheinz; Katrine Grimstrup Joensen; Mette Voldby Larsen
Journal: Bacteriophage Date: 2014-01-22

Phage therapy experience at the Eliava Institute.

1. Impact of relative humidity and collection media on mycobacteriophage D29 aerosol.

2. Evaluation of the Activity of a Combination of Three Bacteriophages Alone or in Association with Antibiotics on Staphylococcus aureus Embedded in Biofilm or Internalized in Osteoblasts.

3. Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections.

4. Storage stability of inhalable phage powders containing lactose at ambient conditions.

5. Applying the ResFinder and VirulenceFinder web-services for easy identification of acquired antibiotic resistance and E. coli virulence genes in bacteriophage and prophage nucleotide sequences.

Review 6. Phage therapy for respiratory infections.

7. Standardized bacteriophage purification for personalized phage therapy.

8. Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models.

Review 9. Therapeutics and delivery vehicles for local treatment of osteomyelitis.

10. Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung.